BioMed Research International / 2019 / Article / Fig 2

Research Article

Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study

Figure 2

(a) Kaplan-Meier survival curves for comparison of OS between TACE + sorafenib group and TACE group (P<0.001). (b) Kaplan-Meier survival curves for comparison of OS between TACE + sorafenib group and TACE group after propensity score matching (P=0.001).

(a)
(b)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.